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Abstract 0 In this paper we will see that PBPK models form part of a larger class of iden-
tifiable models within compartmental analysis. We will also review a method for estimating 
the flow rates in PBPK models based on the Laplace transform, and then via simulations 
we will discuss the performance of this method under the presence of noise and a small set 
of observations, and the role of this method in predicting the duration of effectiveness of a 
drug. 
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Introduction 
A central problem in pharmacology is the relationship between the dose and subsequent 
effect of a drug; in particular, the relationship between a drug's concentration at the targeted 
compartment and its observed response, see Wagner1 , or Holford and Sheiner2 , for instance. 
There are various technical and practical reasons as to why this is a challenging problem. 
Among them is the common situation involving human subjects; that is, it is not possible 
to administer a drug or sample at the targeted compartment, and hence it is not possible 
to directly relate the concentration in this compartment to its observed effect. Furthermore, 
methodology, based on the class of models known as physiologically based compartmental 
(PBPK) models, sometimes is biased in its prediction of the concentration of a drug in the 
targeted compartment from data gathered in some intermediate compartment. This then 
subsequently results in a miscalculation of the concentration in the unobserved targeted 
compartment3 • Consequently, researchers often relate the effect of a drug to the concen-
tration in the sampling compartment, typically the plasma, see Davidian and Giltinan4 , for 
example. 
In this paper, we will compare these two approaches. We first observe that PBPK models 
form part of a larger class of identifiable models within compartmental analysis. Then, we 
will discuss a current method to estimate the flow rates in PBPK models and its ·drawbacks 
in predicting the concentration of a drug in the unobserved compartments. We begin with 
a brief review of compartmental analysis and present new results pertaining to the identifi-
ability of PBPK models. We conclude with some numerical simulations which confirm the 
failure of both approaches to accurately predict the effect of a drug from the concentration in 
the plasma or the concentration in the targeted compartment. However, using the estimate 
of the concentration in the targeted compartment is clearly better if one is interested in the 
duration of the effectiveness of the drug. 
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Models 
One of the common experiments in the pharmacokinetic literature consists of a single or 
a series of bolus injections into the plasma or into the gut, the later being referred to as 
first order absorption or oral administration of a drug, with sampling typically occurring in 
the plasma compartment2•4 • More precisely, a drug's flow through the body is assumed to 
follow linear kinetics from its administration site, say compartment 1 with concentration <fi1 
(arrows indicate direction of flow), to the sampling compartment p, and then to the targeted 
compartment n. It then returns to the plasma compartment from which it leaves the system. 
This is indicated by the following diagram. 
(1) 
where <Pi denotes the concentration in compartment i, aii the flow rate of the drug from 
compartment i to compartment j, and apo refers to the flow rate to the outside of the system 
(corresponding to the arrow pointing out of </Jp)· Then, under the above assumptions, models 
based on diagt:am 1 have convenient closed form solutions. Benet5 obtained closed form 
solu~ions for various common pharmacokinetic experiments via the use of partial fractions 
and the Laplace transform. The reader is referred to Benet5 for details or to Gibaldi and 
Perrier6 or Holford and Sheiner2 for a summary of some of these solutions. However, we 
will see that these solutions are special cases of a more general problem in compartmental 
analysis. 
Compartmental models 
A general compartmental system is commonly described in vector notation as follows, 
d<P (t) 
- A<P + Bu(t), t2:0 dt 
<P(O) 0 (2) 
e(t) - C<P(t), 
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where </J is the concentration vector, u is the input vector, and e the observation vector. In 
scalar notation this is a system of n equations where the ith equation is given by 
In eq 2, A := [aii] is the n X n compartmental matrix representing interaction between 
compartments. Its entries are the unknown flow rates that are to be determined from a set 
of observations. 
To estimate these flow rates or parameters, an experiment is designed in which r inputs enter 
the compartments causing them to interact with one another. The r inputs are regarded 
as the vector, u(t) = (u1(t),u2(t), ... ,ur(t))', where u(t) is the input or forcing function. 
The paths by which the r inputs enter the n compartments is represented by a n x r matrix 
B = [bik], called the input matrix where entry bik is positive if input uk( t) enters compartment 
i, and zero otherwise. Since it is usually not possible to sample each individual compartment, 
a q x n matrix C is introduced and called the sampling matrix. This matrix represents the 
paths from compartments to sampling devices where entry Cii is positive if compartment j 
influences output function component ei(t); otherwise Cii = 0. Then the response function 
is e(t) = (6(t), 6(t), ... , ep(t)). Typically, in experiments involving human subjects, both B 
and C consists of multiples of the natural basis elements, ej, where compartment j is the 
only compartment receiving input or the only compartment being sampled. Through the 
method of variation of parameters7 , the formal solution to eq 2 can be found to be 
(3) 
Pharmacokinetic models 
To see that some of the current pharmacokinetic models are especial cases of a compartmental 
system, we consider a generalization of the models discussed in Holford and Sheiner2 • 
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The system of differential equations resulting from diagram 1, assuming that <P1 receives Di 
units of bolus inputs administered at times ti, can be verified to consist of a bi-diagonal 
compartmental matrix A up to the sampling compartment, </Jp, after which the matrix is 
tri-diagonal. That is, from eq 2 we have that 
d<Pt (t) 
dt 
d<P2 (t) 
dt 
d</Jp (t) 
dt 
d<Pp+I (t) 
dt 
d</Jn (t) 
dt 
- -a12<P1 + L. Dio( t - ti) 
a12<P1 - a23<P2 
ap-t,p<Pp-1- (apo + ap,p+I)<PP 
+ ap+I,p<Pp+I 
ap,p+t<Pp- (ap+l,p + ap+l,p+2)<PP+I 
+ ap+2,p+1 <PP+2 
which can be rewritten as a system 
d~~t) = A<P(t) + Bu(t), 
(4) 
where o( ·) is the Dirac delta function, A is a tri-diagonal n x n compartmental matrix, and 
Bu(t) = Li Dio(t- ti) is the input or forcing function into compartment one orcp1(t). 
As an example of eq 4, consider the two-compartment model with a one time initial oral 
dosage of ~ units used by Westlake3 • These assumptions lead to the following tri-diagonal 
compartmental matrix 
0 0 
A= (5) 
0 
with p = 2, n = 3, input function Bu(t) = e1 ~o(t), and sampling matrix C = e;~ Then the 
solution for any of the compartments is as follows. 
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By using the method of integrating factors we obtain the concentration in compartment one 
to be 
There are several approaches to solve for <f>2(t) and </>3(t), however to be consistent with tradi-
tional approaches, we prefer to treat the solution to compartment one as the forcing function 
in compartment two; that is, we re-define the system by letting (Bu(t))' = ( ~e-a12t, o)' in eq 
2 and consider the lower 2 X 2 block of A, denoted by Ar, as the new compartmental matrix, 
that is, 
Then the new system is 
( !~:~) -
dt . 
which, assuming that a and (3 are the distinct eigenvalues of A and not equal to a12, yields 
the solutions to the two-compartment mode{ with oral administration found in Westlake3 , 
namely 
These are the solutions corresponding to the so called "bolus two-compartment and the first-
order (absorption) one-compartment" models found in Holford and Sheiner2 • 
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Claim 1 It is possible to identify all the entries of A in system eq 4 for a general input 
function u(t) with input matrix B = e1 and sampling matrix C = e~. 
Note that in Claim 1 the choice of p = 1 or p = 2 and n = 4 and Bu(t) = e1 (dose)8(t) 
includes the class of models consider by Holford and Sheiner2• 
Corollary 1 Claim 1 holds for a compartmental matrix A where A, has a mammillary 
structure. 
Estimation 
In general, it is possible to identify up to n + rq( n- 1) parameters or entries of A where this 
number comes from knowledge of the sampling matrix, Cqxn, and input matrix, Bnxr· See 
Anderson8 for further details. While identifiability of the flow rates from a chosen experiment 
is a necessary condition (i.e. for a particular experiment, a sampling and input matrix is 
given and the structure of A is correspondingly well-specified), estimation under the presence 
of noise remains non-trivial even if the problem is identifiable. 
In this section we discuss a known approach to estimating the flow rates based on the Laplace 
transform, see Gibaldi and Perrier6 for a brief discussion or Anderson8 for further details. 
This method need not involve solving the system of differential equations a priori, but rather 
first fitting the data to a sum exponentials (or the solution to the system if available) where 
the number of exponentials corresponds to the size of the compartmental matrix A. That 
is, if A is 3 x 3, then one fits the data to 
To estimate the entries of A, the Laplace transform of g(t) is formed 
ct ~ ca L(g(t))(s) := A + A + A • 
· s - >.1 s - >.2 s - >.a (6) 
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Then, upon obtaining a. common denominator in eq 6, the numerator will be a. polynomial 
of degree two while the denominator will be a polynomial of degree three. One then equates 
these coefficients to those found by calculating the transfer function or the Laplace transform 
of eq 3 
O(sl- At1B · L(u(t))(s). (7) 
So in particular, in eq 7, if we let Bu(t) = ~e1 8(t) then its corresponding Laplace transform 
is L(u(t))(s) = ~e1 and letting 0 = e; with A as given by eq 5, we have that this method 
gives the following nonlinear system of equations to solve for the unknown rates and initial 
dosage~-
-(c1(.X2 + .X3) + c2(.X1 + .X3) + c3(.X1 + .X2)) 
-(cl.X2.X3 + aa.Xl.X3 + c3.Xl.X2) 
-(.XI+ .X2 + .X3) 
~1 ~2 + ~3~1 + ~3~2 
-.Xl.X2.X3 
(8) 
Once the estimated rates are known, and thereby the entries of A, then with this choice of 
A, B, and 0 from eq 3 we find that the solution to the compartmental system is 
</J1 ( t) 
<P(t) := <P2(t) 
<P3(t) 
from which we get the solution in particular at the tissue compartment, </J3(t). 
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(9) 
Numerical Estimation and Duration of Effectiveness 
While this approach has the property that it a priori fits an identifiable model to the data, 
it can yield biased estimates under the presence of noise in the data. Nonetheless, as our 
example will illustrate, when constraints are placed on the flow rates, this estimation method 
yields a better estimate of the duration of effectiveness of a drug. To illustrate this, we 
revisited the oral administration two-compartmental model considered by Westlake3 • For 
this example the true compartmental matrix is 
-2.3888 0 0 
A:= 2.3888 -.7102 .2503 
0 .5413 -.2503 
with initial dosage ~ = .441. We then at fixed times generated 14 observations with normally 
distributed random error and standard deviation .01. Then, using Matlab's subroutines 
leastsq and fsolve (employing the Levenberg-Marquardt option in both) to fit <f>2(t) to the 
data and to solve the system of rates given by eq 8, we have that the estimated matrix of 
flow rates yields 
-1.7459 0 0 
A:= 1.7459 -1.1o11 .3022 
0 .8582 -.3022 
and estimated initial dosage ~ = .5789. The corresponding estimates of the parameters of 
</>2(t) and </>3(t) are 
(&12, &, /3, &32, ~, &23) = (1.7458, 1.3537, .0556, .3022, .5789, .8582). 
v 
To compute the 95% confidence intervals for the parameters of </>2(t) and <f>3 (t), we used 
Matlab's subroutine nlparci and obtained the following range of values for &12, /3, /3, &32, ~' 
and a23 correspondingly 
[(1.6282, 1.8635), (1.2541, 14534), (.0546, .0565), (.2958, .3085), (.5424, .6154), (.7813, .9351)]. 
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Figure 1 shows the true data both in the sampling and unobserved compartment together 
with their estimated curves and corresponding confidence bands. We see that we have over-
estimated the true curve in the unobserved compartment, ¢3(t); while estimated the curve 
in the observed compartment <P2(t) well, as Westlake3 reported. 
However, from Figure 1 we also see that if the effective threshold of a drug (or some pre-
determined level above which the drug has the desired effect) is attained in the tissue com-
partment, then using the plasma level as an approximation to the effective threshold will not 
yield as good of an estimate of the duration of the effectiveness of a drug. This is the case 
since the plasma level time interval is much shorter than that of the tissue level. In fact, 
although we do not report this here, our numerical findings showed this pattern to persist as 
long as the flow rate from compartment two to compartment three is greater than the flow 
rate from compartment two to the outside of the system and if this is also greater than the 
flow rate from compartment three to compartment two. That is, as long as the following 
holds 
Summary 
In this paper, we have seen that PBPK models can be regarded as part of a lhrger class 
of models within compartmental analysis and that PBPK models are well-defined in the 
sense that they come from a family of identifiable compartment models. Moreover, these 
models can be used to predict the concentration in unobserved compartments. However, care 
must be taken, since estimation methodology, such as that primarily based on least squares, 
can lead to bias estimates of the concentration in these unobserved compartments. Further 
investigation is needed to properly account for this bias. Nevertheless, even with these 
inaccurate predictions, this method gives better estimates of the duration of the effectiveness 
of the drug than does the estimate obtained from the plasma compartment. This can be 
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seen from the example but is true for similar examples under plausible constraints on the 
flow rates. 
Appendix 
Proof of Claim 1: 
The method of proof that we will follow consists of breaking up the problem into two pieces. 
Similar to the example previously considered, we will first analyze the compartmental matrix 
only up to the sampling compartment p, showing that this portion is identifiable; that is, 
labeling the upper block of A, Au, where Au is the p X p upper bi-diagonal block of A. The 
solution to this part of the problem will then form the forcing function into compartment p. 
We first establish the claim for the case p = 2. Then the sampling matrix is G = e; and the 
unit bolus input function Bu(t) = e1u(t). Then this gives the impulse-response function 
whose Laplace transform is 
-I -a12 C(si- Au) e1 = · 
s2 + ( a2o + a12)s + a12a2o 
Thus, we see that knowledge of this function determines a2o and a12 uniquely and hence this 
system is identifiable. 
To see if this same choice of G and B allows for the identification of all the rates for a general 
p, the reader can verify that the (p, 1)th_entry of the matrix (sf- Aut1 is 
( -a12)( -a23) ... (-ap-2,p-I)( -ap-I,p) 
(s + a12)(s + a23) ... (s + ap-2,p-I)(s + ap-l,p)(s + apo) · 
From the above, we see that the numerator is a scalar while the denominator is a polynomial 
ins of degree p, this then results in p+ 1 equations in terms of the unknown flow rates; hence, 
it is possible to identify p + 1 unknowns from the chosen experiment. Thus, the experiment 
is identifiable up to this stage. 
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To see that the entire system is identifiable, we proceed by considering the solution ap-l,pt/>p-t(t) 
of the p - 1 th compartment as the forcing function into the pth compartment. That is, we 
take a = e~ and let Bu(t) = et</>p(t). Then to see that the remaining portion is identifi-
able, we recognize the remaining lower block of the compartmental matrix, Az, as catenary 
. 9 
or tri-diagonal, for which, Bellman and Astrom established that with this choice of input 
matrix B and sampling matrix a, that it is possible to identify all of the entries of At. This 
together with the previous result gives us the result that all of A is identifiable. Hence the 
claim is established. 
Proof of Corollary 1: 
The result follows in a similar fashion to Claim 1 and from considering Bellman and Astrom9 's 
work pertaining to mammillary matrices or matrices which have nonzero entries only on their 
first row, column, and diagonal. 
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Figure 1: Estimated concentration t/12(t) and confidence band corresponds to the faster 
descending curves and the'+' and 'o' to the true data. 
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